Cite
HARVARD Citation
Perez-Ruiz, F. et al. (n.d.). FRI0370 Efficacy and safety of lesinurad (RDEA594), a novel URAT1 inhibitor, in combination with allopurinol in allopurinol-refractory gout patients: Results from a randomized, blinded, placebo-controlled, phase 2b extension study. Annals of the rheumatic diseases. p. 439. [Online].